Insulin-like growth factor-I deficiency

Hormone Research

Volumn 55, Issue SUPPL. 1, 2001, Pages 17-20

  Camacho Hübner, Cecilia ^a,b   Savage, Martin ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Department of Endocrinology ^*  (United Kingdom)

Author keywords

GHI; Growth; Growth hormone; IGF I; IGF I system; Insulin insensitivity

Indexed keywords

RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C;

BODY COMPOSITION; BONE METABOLISM; CARBOHYDRATE METABOLISM; CELL GROWTH; CELL PROLIFERATION; CONFERENCE PAPER; DISEASE ASSOCIATION; GENOTYPE; GROWTH REGULATION; HORMONAL REGULATION; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; METABOLIC REGULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METABOLISM;

HUMANS; INSULIN-LIKE GROWTH FACTOR I; MUTATION; RECEPTORS, SOMATOMEDIN; RECOMBINANT PROTEINS; SOMATOMEDINS;

EID: 0034946756     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063457     Document Type: Conference Paper

References (19)

1. Is growth hormone deficiency a viable diagnosis?
2. Intrauterine growth retardation and postnatal growth failure associated with deletion of the IGF-I gene
3. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome)
4. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life
5. Insulin-like growth factors, and their binding proteins
6. Role of insulin-like growth factors in embryonic and postnatal growth
7. Mice carrying null mutations of the genes encoding insulin-like growth factor (IGF-I) a type 1 IGF receptor (IGF1r)
8. IGF-I is required for normal embryonic growth in mice
9. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage dependent manner: Manipulation using the Cre/loxP system in transgenic mice
10. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but it is not required for postnatal growth in mice
11. Effects of recombinant human insulin-like growth factor (IGF)-I therapy on the growth hormone (GH)-IGF system of a patient with a partial IGF-I gene deletion
12. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion
13. The modified minimal model: Application to measurement of insulin-sensitivity in children
14. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome - A clinical research center study
15. Laron syndrome - Clinical features, molecular pathology and treatment
16. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency
17. The effect of recombinant human insulin-like growth factor (IGF)-I treatment of growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome)
18. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: Effect of growth hormone therapy
19. Human IGF-I mutations associated with intrauterine and postnatal growth retardation